Survey Finds QC Best Practices in Clinical Genomics Still Developing
September 14, 2018 - Quality control best practices are still evolving in clinical genomics, according to a survey conducted by SeraCare Life Sciences, a Massachusetts-based developer of laboratory quality control products, in conjunction with GenomeWeb.
The survey queried more than 150 individuals who perform next-generation sequencing in the clinical space about the quality control metrics they use, how they manage QC data, and the time they spend troubleshooting QC issues.
"The largest problem in the state of clinical NGS testing today is the lack of standardization and this survey shows that there is room for improvement across the board," Gregory Tsongalis, director of the Laboratory for Clinical Genomics and Advanced Technology at Dartmouth Hitchcock Medical Center, said in a statement. Tsongalis is a member of SeraCare's scientific advisory board.